Quidelortho Corporation

San Diego, CA ManufacturingNAICS 339110

Self-funded health planPlan year 2025Renews January
3,762Participants-11% vs. prior year
$8.9MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#13 of 61Manufacturing in CABy participants

Overview

Quidelortho Corporation sponsors a self-funded health plan that covered 3,762 participants in plan year 2025, down 11% from the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
3,762 · prior year 4,233
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
Quidelortho Corporation Health and Welfare Plan, plan 501 (3,762 participants)
Broker compensation
$540K across insured contracts
MedicalLife insuranceDentalVisionShort-term disabilityPrepaid legalLong-term disabilitySeveranceDeath benefitsOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Metropolitan Life Insurance CompanyVision, Critical Illness, Hospital Indemnity, Accident, Dental3,040$4.4M$355K
Life Insurance Company of North AmericaAccidental Death & Dismemberment, Long-term disability, Life, Short-term disability4,697$4.3M$167K
Arag Insurance CompanyLegal1,178$161K$16K
Aetna Behavioral Health, LLCEmployee Assistance Program5,537$97K—
Health and Human Resource Center, Inc.Employee Assistance Program966$17K—
Federal Insurance CompanyBusiness Travel Accident3,643——

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$8.9M/ year

Estimated prescription spend: 3,762 participants × $2,371 national average per member. Usually higher once dependents are counted.

$232K–$572K/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$68K–$169K
Lower-cost therapeutic alternatives$99K–$207K
Generic pricing vs. actual cost$43K–$128K
PBM contract terms$22K–$67K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
Quidelortho Corporation
Sponsor EIN
87-4496285
Plan number
501
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 87-4496285 in the Department of Labor's EFAST2 Form 5500 search.

Retirement plan

Plan
Quidelortho Savings and Retirement Plan
Type
401(k) plan
Participants
5,010

About this data

Source: Quidelortho Corporation's Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Quidelortho Corporation.

Request a correction · Methodology